Castleark Management LLC Invests $283,000 in ICU Medical, Inc. (ICUI) Stock

Castleark Management LLC bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,640 shares of the medical instruments supplier’s stock, valued at approximately $283,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Trust Advisors LP boosted its holdings in ICU Medical by 42.0% in the first quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock valued at $1,556,000 after purchasing an additional 3,013 shares during the last quarter. Parametric Portfolio Associates LLC boosted its holdings in ICU Medical by 10.1% in the first quarter. Parametric Portfolio Associates LLC now owns 26,715 shares of the medical instruments supplier’s stock valued at $4,079,000 after purchasing an additional 2,459 shares during the last quarter. Neuberger Berman Group LLC boosted its holdings in ICU Medical by 37.7% in the first quarter. Neuberger Berman Group LLC now owns 1,915 shares of the medical instruments supplier’s stock valued at $292,000 after purchasing an additional 524 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its holdings in ICU Medical by 1.2% in the first quarter. Municipal Employees Retirement System of Michigan now owns 3,360 shares of the medical instruments supplier’s stock valued at $513,000 after purchasing an additional 40 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in ICU Medical by 2.3% in the first quarter. Legal & General Group Plc now owns 26,185 shares of the medical instruments supplier’s stock valued at $3,998,000 after purchasing an additional 592 shares during the last quarter. 78.14% of the stock is owned by institutional investors.

ICUI has been the subject of a number of analyst reports. BidaskClub downgraded ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $195.00 target price on the stock in a report on Wednesday, July 12th. Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Finally, KeyCorp began coverage on ICU Medical in a report on Tuesday, October 17th. They set a “sector weight” rating on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $193.00.

WARNING: “Castleark Management LLC Invests $283,000 in ICU Medical, Inc. (ICUI) Stock” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/10/27/1640-shares-in-icu-medical-inc-icui-acquired-by-castleark-management-llc.html.

Shares of ICU Medical, Inc. (NASDAQ ICUI) opened at 189.00 on Friday. ICU Medical, Inc. has a 12 month low of $127.00 and a 12 month high of $195.20. The firm has a market capitalization of $3.75 billion, a PE ratio of 75.69 and a beta of 0.35. The stock’s 50 day moving average price is $185.49 and its 200-day moving average price is $170.77.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). The business had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The firm’s quarterly revenue was up 242.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.15 earnings per share. On average, equities analysts anticipate that ICU Medical, Inc. will post $4.12 earnings per share for the current fiscal year.

In related news, VP Virginia Ruth Sanzone sold 1,784 shares of the business’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $174.47, for a total transaction of $311,254.48. Following the transaction, the vice president now directly owns 102 shares in the company, valued at $17,795.94. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Vivek Jain sold 2,200 shares of the business’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $190.91, for a total transaction of $420,002.00. Following the transaction, the chief executive officer now owns 44,111 shares in the company, valued at $8,421,231.01. The disclosure for this sale can be found here. Insiders have sold 120,247 shares of company stock valued at $22,708,888 over the last quarter. Corporate insiders own 13.60% of the company’s stock.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply